08:00 , Mar 22, 2004 |  BioCentury  |  Finance

Ebb & Flow

Watchers of Warburg Pincus investments in public biotech companies might think they are seeing a pattern: large stakes, two board seats and an M&A deal on the horizon. Thus, if coincidence isn't at work, it...
08:00 , Mar 16, 2004 |  BC Extra  |  Financial News

TaiGen raises $38M

TaiGen (Taipei, Taiwan) raised $38 million in a series B round led by China Steel. Other investors included MPM Capital; Development Fund; YFY Group; China Development Industrial Bank; Shin Kong Life Insurance; and Cathay Life...
07:00 , Aug 27, 2001 |  BioCentury  |  Strategy

Testing the tech transfer model

TaiGen Biotechnology Co. Ltd. 's financing and technology deal with Arena Pharmaceuticals Inc. demonstrates the power of personal relationships as well as providing the most high-profile milestone in the effort to build a fledgling biotechnology...
07:00 , Aug 27, 2001 |  BioCentury  |  Strategy

Testing the tech transfer model

TaiGen Biotechnology Co. Ltd. 's financing and technology deal with Arena Pharmaceuticals Inc. demonstrates the power of personal relationships as well as providing the most high-profile milestone in the effort to build a fledgling biotechnology...
07:00 , Aug 27, 2001 |  BioCentury  |  Finance

Ebb & Flow

Most of the private companies that raised money in the first half of 2000 - when the genomics "revolution" was driving super-high octane valuations - bought about a year-and-a-half of cash, which would put them...
07:00 , Aug 20, 2001 |  BC Extra  |  Company News

Arena, TaiGen in CART deal

ARNA licensed to TaiGen Biotechnology (Taipei, Taiwan) the right to select validated screening assays that include CART-activated G protein-coupled receptors to develop targeted therapeutics in exchange for first right of negotiation, milestones, and royalties on...